4

OWNERSHIP DOCUMENT

Company: Matinas BioPharma Holdings, Inc.
Filed: February 12, 2019
Period of Report: February 8, 2019
Accession Number: 0000905718-19-000106

View Document ↗ View on SEC.gov ↗